Efficacy of therapies targeted at treating patients with membranous glomerulonephritis

Ethnicity and Disease

Volumn 15, Issue 3 SUPPL. 4, 2005, Pages

  Zhuo, David X ^a   Hanna Johnson, Melanie ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DATA ANALYSIS; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPOTHESIS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; META ANALYSIS; MONOTHERAPY; PATIENT CARE; REMISSION; SIDE EFFECT; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 27544455161     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Cattran DC. Membranous nephropathy: Quo vadis? Kidney Int. 2002;61:349-350.
2. Cattran DC, Delmore T, Roscoe J, et al. A randomized controlled trial of prednisone in patients with idiopathic membranous nephropathy. N Engl J Med 1989;320:210-215.
3. Miller G, Zimmerman R III, Radhakrishnan J, et al. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis. 2000;36:250-256.
4. Bagga A, Hari P, Moudgil A, et al. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis. 2003;42:1114-1120.
5. Branten AJW, Wetzels JFM. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Clin Nephrol. 2001;56:1-9.